BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 26253584)

  • 1. Health resource utilization associated with skeletal-related events: results from a retrospective European study.
    Body JJ; Pereira J; Sleeboom H; Maniadakis N; Terpos E; Acklin YP; Finek J; Gunther O; Hechmati G; Mossman T; Costa L; Rogowski W; Nahi H; von Moos R
    Eur J Health Econ; 2016 Jul; 17(6):711-21. PubMed ID: 26253584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost of skeletal complications from bone metastases in six European countries.
    Pereira J; Body JJ; Gunther O; Sleeboom H; Hechmati G; Maniadakis N; Terpos E; Acklin YP; Finek J; von Moos R
    J Med Econ; 2016 Jun; 19(6):611-8. PubMed ID: 26849381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Payer costs for inpatient treatment of pathologic fracture, surgery to bone, and spinal cord compression among patients with multiple myeloma or bone metastasis secondary to prostate or breast cancer.
    Barlev A; Song X; Ivanov B; Setty V; Chung K
    J Manag Care Pharm; 2010; 16(9):693-702. PubMed ID: 21067255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathologic fracture and healthcare resource utilisation: A retrospective study in eight European countries.
    Body JJ; Acklin YP; Gunther O; Hechmati G; Pereira J; Maniadakis N; Terpos E; Finek J; von Moos R; Talbot S; Sleeboom H
    J Bone Oncol; 2016 Nov; 5(4):185-193. PubMed ID: 28008381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health resource utilisation associated with skeletal-related events in patients with bone metastases secondary to solid tumours: regional comparisons in an observational study.
    Duran I; Fink MG; Bahl A; Hoefeler H; Mahmood A; Lüftner D; Ghazal H; Wei R; Chung KC; Hechmati G; Green J; Atchison C
    Eur J Cancer Care (Engl); 2017 Nov; 26(6):. PubMed ID: 26865392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healthcare-resource utilization associated with radiation to bone across eight European countries: Results from a retrospective study.
    von Moos R; Body JJ; Guenther O; Terpos E; Acklin YP; Finek J; Pereira J; Maniadakis N; Hechmati G; Talbot S; Sleeboom H
    J Bone Oncol; 2018 Mar; 10():49-56. PubMed ID: 29577024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost of skeletal-related events in European patients with solid tumours and bone metastases: data from a prospective multinational observational study.
    Hechmati G; Cure S; Gouépo A; Hoefeler H; Lorusso V; Lüftner D; Duran I; Garzon-Rodriguez C; Ashcroft J; Wei R; Ghelani P; Bahl A
    J Med Econ; 2013; 16(5):691-700. PubMed ID: 23441975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canadian health care institution resource utilization resulting from skeletal-related events.
    Habib MJ; Merali T; Mills A; Uon V
    Hosp Pract (1995); 2014 Feb; 42(1):15-22. PubMed ID: 24566592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health resource utilization associated with skeletal-related events in patients with advanced breast cancer: results from a prospective, multinational observational study.
    Lüftner D; Lorusso V; Duran I; Hechmati G; Garzon-Rodriguez C; Ashcroft J; Bahl A; Ghelani P; Wei R; Thomas E; Hoefeler H
    Springerplus; 2014; 3():328. PubMed ID: 25045611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost analysis of skeletal-related events in Spanish patients with bone metastases from solid tumours.
    Durán I; Garzón C; Sánchez A; García-Carbonero I; Pérez-Gracia JL; Seguí-Palmer MÁ; Wei R; Restovic G; Gasquet JA; Gutiérrez L
    Clin Transl Oncol; 2014 Mar; 16(3):322-9. PubMed ID: 23943561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health resource utilization associated with skeletal-related events in patients with bone metastases: Results from a multinational retrospective - prospective observational study - a cohort from 4 European countries.
    Hoefeler H; Duran I; Hechmati G; Garzon Rodriguez C; Lüftner D; Ashcroft J; Bahl A; Atchison C; Wei R; Thomas E; Lorusso V
    J Bone Oncol; 2014 May; 3(2):40-8. PubMed ID: 26909296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of skeletal-related events in patients with breast or prostate cancer-induced bone metastasis or multiple myeloma: A 12-year longitudinal nationwide healthcare database study.
    Baek YH; Jeon HL; Oh IS; Yang H; Park J; Shin JY
    Cancer Epidemiol; 2019 Aug; 61():104-110. PubMed ID: 31176960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic burden of skeletal-related events in patients with multiple myeloma: analysis of US commercial claims database.
    Bhowmik D; Hines DM; Intorcia M; Wade RL
    J Med Econ; 2018 Jun; 21(6):622-628. PubMed ID: 29571273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The economic burden of skeletal-related events among elderly men with metastatic prostate cancer.
    Jayasekera J; Onukwugha E; Bikov K; Mullins CD; Seal B; Hussain A
    Pharmacoeconomics; 2014 Feb; 32(2):173-91. PubMed ID: 24435407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthcare resource utilisation associated with skeletal-related events in European patients with multiple myeloma: Results from a prospective, multinational, observational study.
    Ashcroft J; Duran I; Hoefeler H; Lorusso V; Lueftner D; Campioni M; Intorcia M; Bahl A
    Eur J Haematol; 2018 May; 100(5):479-487. PubMed ID: 29444353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health Resource Utilization Associated with Skeletal-Related Events in Patients with Advanced Prostate Cancer: A European Subgroup Analysis from an Observational, Multinational Study.
    Bahl A; Hoefeler H; Duran I; Hechmati G; Garzon-Rodriguez C; Ashcroft J; Lorusso V; Ghelani P; Wei R; Thomas E; Lüftner D
    J Clin Med; 2014 Jul; 3(3):883-96. PubMed ID: 26237483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health resource utilisation associated with skeletal-related events in European patients with lung cancer: Α subgroup analysis from a prospective multinational study.
    Lorusso V; Duran I; Garzon-Rodriguez C; Lüftner D; Bahl A; Ashcroft J; Hechmati G; Wei R; Thomas E; Hoefeler H
    Mol Clin Oncol; 2014 Sep; 2(5):701-708. PubMed ID: 25054033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic evaluation of denosumab compared with zoledronic acid in hormone-refractory prostate cancer patients with bone metastases.
    Xie J; Namjoshi M; Wu EQ; Parikh K; Diener M; Yu AP; Guo A; Culver KW
    J Manag Care Pharm; 2011 Oct; 17(8):621-43. PubMed ID: 21942303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospital visits among women with skeletal-related events secondary to breast cancer and bone metastases: a nationwide population-based cohort study in Denmark.
    Svendsen ML; Gammelager H; Sværke C; Yong M; Chia VM; Christiansen CF; Fryzek JP
    Clin Epidemiol; 2013; 5():97-103. PubMed ID: 23576882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The economic burden associated with skeletal-related events in patients with bone metastases secondary to solid tumors in Belgium.
    Body JJ; Chevalier P; Gunther O; Hechmati G; Lamotte M
    J Med Econ; 2013; 16(4):539-46. PubMed ID: 23425250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.